» Articles » PMID: 9790573

Epithelial Transport in Polycystic Kidney Disease

Overview
Journal Physiol Rev
Specialty Physiology
Date 1998 Oct 28
PMID 9790573
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

In autosomal dominant polycystic kidney disease (ADPKD), the genetic defect results in the slow growth of a multitude of epithelial cysts within the renal parenchyma. Cysts originate within the glomeruli and all tubular structures, and their growth is the result of proliferation of incompletely differentiated epithelial cells and the accumulation of fluid within the cysts. The majority of cysts disconnect from tubular structures as they grow but still accumulate fluid within the lumen. The fluid accumulation is the result of secretion of fluid driven by active transepithelial Cl- secretion. Proliferation of the cells and fluid secretion are activated by agonists of the cAMP signaling pathway. The transport mechanisms involved include the cystic fibrosis transmembrane conductance regulator (CFTR) present in the apical membrane of the cystic cells and a bumetanide-sensitive transporter located in the basolateral membrane. A lipid factor, called cyst activating factor, has been found in the cystic fluid. Cyst activating factor stimulates cAMP production, proliferation, and fluid secretion by cultured renal epithelial cells and also is a chemotactic agent. Cysts also appear in the intrahepatic biliary tree in ADPKD. Normal ductal cells secrete Cl- and HCO3-. The cystic ductal cell also secretes Cl-, but HCO3- secretion is diminished, probably as the result of a lower population of Cl-/HCO3- exchangers in the apical membrane as compared with the normal cells. Some segments of the normal renal tubule are also capable of utilizing CFTR to secrete Cl-, particularly the inner medullary collecting duct. The ability of Madin-Darby canine kidney cells and normal human kidney cortex cells to form cysts in culture and to secrete fluid and the functional similarities between these incompletely differentiated, proliferative cells and developing cells in the intestinal crypt and in the fetal lung have led us to suggest that Cl- and fluid secretion may be a common property of at least some renal epithelial cells in an intermediate stage of development. The genetic defect in ADPKD may not directly affect membrane transport mechanisms but rather may arrest the development of certain renal epithelial cells in an incompletely differentiated, proliferative stage.

Citing Articles

Plant-derived compounds for treating autosomal dominant polycystic kidney disease.

Zhang J, Chen J, Xu J, Xue C, Mao Z Front Nephrol. 2023; 3:1071441.

PMID: 37675342 PMC: 10479581. DOI: 10.3389/fneph.2023.1071441.


CFTR and PC2, partners in the primary cilia in autosomal dominant polycystic kidney disease.

Yanda M, Ciobanu C, Guggino W, Cebotaru L Am J Physiol Cell Physiol. 2023; 325(3):C682-C693.

PMID: 37519231 PMC: 10635646. DOI: 10.1152/ajpcell.00197.2023.


Urinary exosome proteomic profiling defines stage-specific rapid progression of autosomal dominant polycystic kidney disease and tolvaptan efficacy.

Raby K, Horsely H, McCarthy-Boxer A, Norman J, Wilson P BBA Adv. 2023; 1:100013.

PMID: 37082007 PMC: 10074914. DOI: 10.1016/j.bbadva.2021.100013.


TRPV4 functional status in cystic cells regulates cystogenesis in autosomal recessive polycystic kidney disease during variations in dietary potassium.

Pyrshev K, Stavniichuk A, Tomilin V, Khayyat N, Ren G, Kordysh M Physiol Rep. 2023; 11(6):e15641.

PMID: 36946001 PMC: 10031299. DOI: 10.14814/phy2.15641.


Kidney epithelial cells are active mechano-biological fluid pumps.

Choudhury M, Li Y, Mistriotis P, Vasconcelos A, Dixon E, Yang J Nat Commun. 2022; 13(1):2317.

PMID: 35484146 PMC: 9050750. DOI: 10.1038/s41467-022-29988-w.